Exservan is a Oral Film in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is Riluzole.
| Product ID | 70510-2202_f981ebe9-f931-4b4e-b7d1-2133f7aa6d66 |
| NDC | 70510-2202 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Exservan |
| Generic Name | Riluzole |
| Dosage Form | Film |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-05-01 |
| Marketing Category | NDA / |
| Application Number | NDA212640 |
| Labeler Name | Mitsubishi Tanabe Pharma America, Inc. |
| Substance Name | RILUZOLE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Benzothiazole [EPC],Benzothiazoles [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10094-350 | EXSERVAN | riluzole |
| 70510-2201 | Exservan | riluzole |
| 70510-2202 | Exservan | riluzole |
| 70515-700 | Rilutek | riluzole |
| 0378-4145 | Riluzole | riluzole |
| 42291-775 | Riluzole | riluzole |
| 60505-3285 | RILUZOLE | RILUZOLE |
| 62756-538 | Riluzole | Riluzole |
| 64980-191 | Riluzole | riluzole |
| 67877-286 | Riluzole | Riluzole |
| 68084-908 | RILUZOLE | RILUZOLE |
| 68462-381 | riluzole | riluzole |
| 69076-200 | Riluzole | riluzole |
| 69076-611 | Riluzole | Riluzole |
| 70726-0303 | TIGLUTIK | Riluzole |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EXSERVAN 90792818 not registered Live/Pending |
Aquestive Therapeutics, Inc. 2021-06-24 |
![]() EXSERVAN 90303402 not registered Live/Pending |
AQUESTIVE THERAPEUTICS, INC. 2020-11-06 |
![]() EXSERVAN 87512075 not registered Live/Pending |
AQUESTIVE THERAPEUTICS, INC. 2017-06-30 |